Terminalia ferdinandiana
Terminalia ferdinandiana · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Terminalia ferdinandiana is a remarkable plant species known for its potent medicinal properties derived from its fruit and leaves. Scientific studies have highlighted that its extracts are rich in bioactive chemicals, particularly powerful antioxidants and tannins. These components provide significant antioxidant activities that help combat various physiological stressors. Consequently, the plant shows great promise in managing conditions such as cancer, cardiovascular diseases, inflammation, and giardiasis. This makes the species a subject of intense interest for developing natural therapeutic interventions.
- Synonyms
- Terminalia Latipes Subsp. Psilocarpa
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Fruit · Leaf
Classification
Common Names
Terminalia ferdinandiana is a remarkable species known by a diverse array of names across different cultures and languages. In English-speaking regions, it is most frequently referred to as the Kakadu Plum or the Ameixa-kakadú. Some local or specialized circles may also call it the Mador, adding to its linguistic variety. It even carries the unique designation of vrcholiak Ferdinandov in certain contexts. Finally, its international appeal is reflected in its Chinese name, 卡卡杜李.
Sources: Catalogue of Life (COL)
Synonyms
Terminalia ferdinandiana is a significant species often identified by its botanical synonym, Terminalia latipes subsp. psilocarpa. This taxonomic relationship highlights the intricate classification systems used to categorize unique flora. Understanding these overlapping names is essential for researchers studying the plant's specific evolutionary lineage. By recognizing both designations, botanists can ensure accuracy when documenting its presence in various ecosystems. Consequently, these synonymous terms provide a more comprehensive framework for identifying this important tree.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Terminalia ferdinandiana belongs to the vast kingdom Plantae, representing a significant part of the natural world. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the order Myrtales, which helps scientists understand its evolutionary lineage. This plant is a member of the Combretaceae family, a group known for its diverse botanical characteristics. Finally, it is identified by its specific genus, Terminalia, which defines its core biological identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Terminalia ferdinandiana is a notable species found throughout the expansive region of Australasia. Its natural distribution spans several key areas within Australia, showcasing its adaptability to various environments. Specifically, this plant can be found thriving across the rugged landscapes of the Northern Territory. It also maintains a significant presence in the tropical regions of Queensland. Furthermore, its reach extends westward into the diverse ecosystems of Western Australia.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Terminalia ferdinandiana is a self-supporting species characterized by its distinct tree growth form. This resilient plant exhibits significant variability in stature depending on its environmental conditions. While some specimens may only reach a minimum height of 1 meter, others can develop into much larger structures. Many mature individuals easily surpass the 10-meter mark as they establish themselves. Ultimately, these trees can reach a maximum height of 14 meters in ideal growing locations.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Terminalia ferdinandiana is an endemic Australian plant recognized for its high concentration of bioactive phytochemicals, including tannins and flavonoids. Research highlights that this species possesses significant antioxidant activity, which helps alleviate oxidative stress induced by hydrogen peroxide. Specifically, extracts rich in ellagic acid have been shown to reduce the production of reactive oxygen species in various mammalian cell lines. By upregulating antioxidative genes like superoxide dismutase, the plant demonstrates a strong capacity to combat cellular damage. These potent antioxidant properties suggest that the plant holds great promise for preventing diseases related to oxidative damage and inflammation.
Compounds
Terminalia ferdinandiana is an endemic Australian plant that possesses a remarkable profile of bioactive compounds. Research highlights that the plant is characterized by high tannin contents, which contribute to its strong antibacterial properties. Furthermore, the fruit is an extraordinary source of antioxidants, boasting ascorbic acid levels that exceed those of blueberries by more than 900 times. These potent chemical constituents allow the plant to effectively scavenge free radicals and protect cells from oxidative stress. Given this unique phytochemical makeup, the species holds significant promise for the development of new medicinal therapies.
Conditions
Terminalia ferdinandiana extracts demonstrate significant medicinal potential by inhibiting the growth and proliferation of the parasite Giardia duodenalis. The plant also shows strong antibacterial efficacy through the inhibition of methicillin-resistant Staphylococcus aureus (MRSA). Furthermore, its high antioxidant content is linked to valuable antidiabetic bioactivities. These bioactive properties also suggest a role in the prevention and treatment of cancer. Together, these findings highlight the plant's diverse therapeutic capabilities against various pathogens and metabolic conditions.
Preparations
Terminalia ferdinandiana is prepared as various types of extracts, including methanolic, aqueous, ethyl acetate, chloroform, and hexane versions. These fruit-derived extracts are specifically investigated for their ability to inhibit the proliferation of the parasite Giardia duodenalis. Among these preparations, the methanolic and aqueous extracts demonstrate the most potent inhibitory activity against the pathogen. While ethyl acetate and chloroform extracts also show effectiveness, the hexane extract lacks any inhibitory properties. Ultimately, the low toxicity and bioactive nature of these Terminalia ferdinandiana extracts suggest they could serve as medicinal agents for treating giardiasis.
Parts used
Terminalia ferdinandiana is an endemic Australian plant that possesses significant medicinal potential due to its rich phytochemical profile. Both the fruit and the leaf of this species serve as vital components for extracting bioactive compounds like antioxidants, tannins, and flavonoids. Research indicates that the fruit is an exceptionally high source of ascorbic acid, far surpassing the levels found in blueberries. Furthermore, extracts derived from both the leaf and the fruit have demonstrated strong antibacterial activity against pathogens such as MRSA. These diverse properties suggest that utilizing the different parts of the plant could lead to innovative treatments for various diseases.